Cargando…
MON-239 Pituitary Apoplexy Induced by Gonadotropin-Releasing Hormone Agonist Administration: A Rare Complication of Prostate Cancer Treatment
Background: Pituitary apoplexy is a potentially life-threatening clinical condition associated with bleeding and/or infarction into the pituitary gland, usually within a tumor. Gonadotropin-releasing hormone (GnRH) agonists, currently used in the treatment of advanced prostate cancer, have been desc...
Autores principales: | Barbosa, Mariana Marques, Paredes, Sílvia Cristina de Sousa, Machado, Maria João, Almeida, Rui, Marques, Olinda Castro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208172/ http://dx.doi.org/10.1210/jendso/bvaa046.1515 |
Ejemplares similares
-
Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021) -
PMON91 Late Presentation of Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist for Prostate Cancer Treatment
por: Raj, Rishi, et al.
Publicado: (2022) -
Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment
por: Barbosa, Mariana, et al.
Publicado: (2020) -
MON-252 Pituitary Tumor Apoplexy Presenting with Acute Psychosis
por: Pineyro, Maria Mercedes, et al.
Publicado: (2020) -
MON-408 Development of Rapidly Progressive Cushing's Disease Following Pituitary Apoplexy Several Years Prior
por: Ortegon Zambrano, Pilar, et al.
Publicado: (2019)